RU2018126158A3 - - Google Patents

Download PDF

Info

Publication number
RU2018126158A3
RU2018126158A3 RU2018126158A RU2018126158A RU2018126158A3 RU 2018126158 A3 RU2018126158 A3 RU 2018126158A3 RU 2018126158 A RU2018126158 A RU 2018126158A RU 2018126158 A RU2018126158 A RU 2018126158A RU 2018126158 A3 RU2018126158 A3 RU 2018126158A3
Authority
RU
Russia
Application number
RU2018126158A
Other languages
Russian (ru)
Other versions
RU2018126158A (ru
RU2759916C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018126158A publication Critical patent/RU2018126158A/ru
Publication of RU2018126158A3 publication Critical patent/RU2018126158A3/ru
Application granted granted Critical
Publication of RU2759916C2 publication Critical patent/RU2759916C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
RU2018126158A 2015-12-31 2016-12-28 Применение триацетил-3-гидроксифениладенозина для получения фармацевтического лекарственного средства для предупреждения или лечения неалкогольной жировой болезни печени RU2759916C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201511034199 2015-12-31
CN201511034199.0 2015-12-31
PCT/CN2016/112623 WO2017114413A1 (zh) 2015-12-31 2016-12-28 三乙酰基-3-羟基苯基腺苷在制备预防或者治疗非酒精性脂肪肝药物中的应用

Publications (3)

Publication Number Publication Date
RU2018126158A RU2018126158A (ru) 2020-01-31
RU2018126158A3 true RU2018126158A3 (enExample) 2020-03-11
RU2759916C2 RU2759916C2 (ru) 2021-11-18

Family

ID=59224622

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018126158A RU2759916C2 (ru) 2015-12-31 2016-12-28 Применение триацетил-3-гидроксифениладенозина для получения фармацевтического лекарственного средства для предупреждения или лечения неалкогольной жировой болезни печени

Country Status (11)

Country Link
US (1) US11058703B2 (enExample)
EP (1) EP3398604A4 (enExample)
JP (1) JP7382716B2 (enExample)
KR (1) KR102676056B1 (enExample)
CN (2) CN106943420A (enExample)
AU (1) AU2016383376B2 (enExample)
CA (1) CA3010097C (enExample)
HK (1) HK1255689A1 (enExample)
RU (1) RU2759916C2 (enExample)
WO (1) WO2017114413A1 (enExample)
ZA (1) ZA201805080B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107334775A (zh) * 2016-03-14 2017-11-10 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷在制备治疗动脉粥样硬化药物中的应用
KR20210016407A (ko) * 2018-06-05 2021-02-15 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 대사 장애 및 비알코올성 지방 간 질환의 치료를 위한 활성제 및 그 사용 방법
CN111821313A (zh) * 2019-04-17 2020-10-27 江苏天士力帝益药业有限公司 三乙酰基-3-羟基苯基腺苷在制备抑制心脏纤维化的药物中的应用
CN114869901B (zh) * 2022-05-06 2023-10-27 安徽医科大学 马鞭草苷在治疗酒精性肝损伤药物中的应用
CN117599076A (zh) * 2023-11-15 2024-02-27 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷在制备运动模拟药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005132812A (ja) 2003-10-08 2005-05-26 Kobayashi Pharmaceut Co Ltd シイタケ菌糸体抽出物の分画物およびその用途
CN100427534C (zh) * 2004-03-19 2008-10-22 四川大学 聚合物型含磷阻燃剂及其制备方法和用途
JP2007210926A (ja) 2006-02-08 2007-08-23 Tokyo Univ Of Pharmacy & Life Science ピラジンカルボン酸化合物からなる薬剤、及び食餌
CN101712709A (zh) 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
JP5688229B2 (ja) 2010-03-19 2015-03-25 国立大学法人名古屋大学 肝保護作用を有するタンパク質、肝障害予防・保護用化合物のスクリーニング方法
CN102125580A (zh) * 2011-01-17 2011-07-20 泰山医学院 三乙酰基-3-羟基苯基腺苷thpa在制药中的应用
ME02312B (me) * 2011-04-22 2016-06-20 Pfizer DERIVATI PIRAZOLOSPIROKETONA, NAMIJENJENI UPOTREBI KAO INHIBITORI ACETIL-CoA-KARBOKSILAZE
AU2013204500A1 (en) 2012-09-21 2014-04-10 Barbara Jane Badenoch-Jones Novel AMPK agonist compositions and methods of use
CN103191145A (zh) 2013-03-27 2013-07-10 南京理工大学 腺苷及其衍生物在防治药物性肝损伤中的应用
CN104211747B (zh) * 2013-05-29 2018-09-25 中国医学科学院药物研究所 5’-磷酸-n6-(3-羟基苯基)腺苷的制备及医药用途
US9827222B2 (en) 2013-07-01 2017-11-28 Emory University Treating or preventing nephrogenic diabetes insipidus
CN104546887B (zh) * 2013-10-09 2018-10-30 中国医学科学院药物研究所 虫草素衍生物治疗炎症疾病的用途
CN105663152A (zh) 2014-11-19 2016-06-15 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷在制备改善胰岛素抵抗及相关疾病中的应用
CN107334775A (zh) * 2016-03-14 2017-11-10 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷在制备治疗动脉粥样硬化药物中的应用

Also Published As

Publication number Publication date
JP7382716B2 (ja) 2023-11-17
US20190022120A1 (en) 2019-01-24
AU2016383376B2 (en) 2022-07-28
CA3010097C (en) 2023-08-22
KR20180100152A (ko) 2018-09-07
RU2018126158A (ru) 2020-01-31
AU2016383376A1 (en) 2018-07-12
EP3398604A1 (en) 2018-11-07
CN106943420A (zh) 2017-07-14
US11058703B2 (en) 2021-07-13
JP2019500379A (ja) 2019-01-10
KR102676056B1 (ko) 2024-06-19
CA3010097A1 (en) 2017-07-06
ZA201805080B (en) 2019-10-30
EP3398604A4 (en) 2019-06-19
WO2017114413A1 (zh) 2017-07-06
CN118178446A (zh) 2024-06-14
RU2759916C2 (ru) 2021-11-18
HK1255689A1 (en) 2019-08-23

Similar Documents

Publication Publication Date Title
BR112018002757A2 (enExample)
BR122019018154A2 (enExample)
BR112018005637A2 (enExample)
BR112018002726A2 (enExample)
BR112018004237A2 (enExample)
BR112016001296A2 (enExample)
RU2018126158A3 (enExample)
BR0009349B1 (enExample)
BR0008719B1 (enExample)
CN303070847S (enExample)
CN303069374S (enExample)
CN303065944S (enExample)
BR0315952B1 (enExample)
BR0306242B1 (enExample)
BR0113334B1 (enExample)
BR0303428B1 (enExample)
BR0204702B1 (enExample)
BR0009994B1 (enExample)
BR0009942B1 (enExample)
BR0009761B1 (enExample)
BR0009757B1 (enExample)
BR0009717B1 (enExample)
BR0009649B1 (enExample)
BR0009373B1 (enExample)
BR0302202B1 (enExample)